Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease

Mitochondrial Dysfunction in Parkinson's Disease

(2015) Hyo Eun Moon et al.   Experimental Neurobiology

Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction

(2014) Christopher A. Ross et al.   MOVEMENT DISORDERS

The benefits of pramipexole selection in the treatment of Parkinson’s disease

(2014) Mine Silindir et al.   NEUROLOGICAL SCIENCES

Safinamide for the treatment of Parkinson’s disease

(2014) Rukmini Mridula Kandadai et al.   Expert Review of Clinical Pharmacology

Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease

(2013) Anubhuti Dixit et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Current status of safinamide for the drug portfolio of Parkinson’s disease therapy

(2013) Thomas Müller   Expert Review of Neurotherapeutics

Interaction of the antibiotic minocycline with liver mitochondria - role of membrane permeabilization in the impairment of respiration

(2013) Peter Schönfeld et al.   FEBS Journal

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model

(2013) Laurie H. Sanders et al.   FREE RADICAL BIOLOGY AND MEDICINE

Parkinson disease: from pathology to molecular disease mechanisms

(2013) David T. Dexter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Pesticides, Microglial NOX2, and Parkinson's Disease

(2013) Thomas Taetzsch et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Exposure to pesticides or solvents and risk of Parkinson disease

(2013) G. Pezzoli et al.   NEUROLOGY

Autophagy and apoptosis dysfunction in neurodegenerative disorders

(2013) Saeid Ghavami et al.   PROGRESS IN NEUROBIOLOGY

Paths from Pesticides to Parkinson's

(2013) F. Kamel   SCIENCE

The mitochondrial permeability transition pore: a mystery solved?

(2013) Paolo Bernardi   Frontiers in Physiology

Role of Oxidative Stress in Parkinson's Disease

(2013) Onyou Hwang   Experimental Neurobiology

The mitochondrial permeability transition pore (PTP) — An example of multiple molecular exaptation?

(2012) Angelo Vianello et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Physiological Roles of the Permeability Transition Pore

(2012) Catherine Brenner et al.   CIRCULATION RESEARCH

Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models

(2012) Jason R. Cannon et al.   NEUROBIOLOGY OF DISEASE

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

(2012) David N. Hauser et al.   NEUROBIOLOGY OF DISEASE

Mitochondrial Quality Control and Dynamics in Parkinson's Disease

(2011) Melissa K. McCoy et al.   ANTIOXIDANTS & REDOX SIGNALING

Mitochondrial Dynamics and Parkinson's Disease: Focus on Parkin

(2011) Kah-Leong Lim et al.   ANTIOXIDANTS & REDOX SIGNALING

Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis

(2011) Andrea Rasola et al.   CELL CALCIUM

Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases

(2011) P. H. Reddy et al.   Current Alzheimer Research

Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder

(2011) Yuzuru Imai et al.   CURRENT OPINION IN NEUROBIOLOGY

Etiology and pathogenesis of Parkinson's disease

(2011) Anthony H. Schapira et al.   MOVEMENT DISORDERS

The dopamine-D2-receptor agonist ropinirole dose-dependently blocks the Ca2+-triggered permeability transition of mitochondria

(2010) Suhel Parvez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

(2010) Karen Nuytemans et al.   HUMAN MUTATION

Mitochondrial Quality Control and Parkinson’s Disease: A Pathway Unfolds

(2010) Inês Pimenta de Castro et al.   MOLECULAR NEUROBIOLOGY

Missing pieces in the Parkinson's disease puzzle

(2010) Jose A Obeso et al.   NATURE MEDICINE

Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity

(2010) Orly Weinreb et al.   PROGRESS IN NEUROBIOLOGY

Mitochondria, calcium and cell death: A deadly triad in neurodegeneration

(2009) Fulvio Celsi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Mitochondrial dysfunction in Parkinson's disease

(2009) Konstanze F. Winklhofer et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

NMR studies of an immunomodulatory benzodiazepine binding to its molecular target on the mitochondrial F1F0-ATPase

(2009) Andrew C. Stelzer et al.   BIOPOLYMERS

Interaction of mitochondrial potassium channels with the permeability transition pore

(2009) Yu Cheng et al.   FEBS LETTERS

Crosstalk signaling between mitochondrial Ca2+ and ROS

(2009) Robert et al.   Frontiers in Bioscience-Landmark

Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore

(2008) Anna W.C. Leung et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

(2008) Rebecca Banerjee et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The enigma of caspase-2: the laymen's view

(2008) G Krumschnabel et al.   CELL DEATH AND DIFFERENTIATION

Mitochondrial alterations in Parkinson’s disease: new clues

(2008) Miquel Vila et al.   JOURNAL OF NEUROCHEMISTRY